These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32611683)

  • 1. An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients.
    Mann JL; Maikawa CL; Smith AAA; Grosskopf AK; Baker SW; Roth GA; Meis CM; Gale EC; Liong CS; Correa S; Chan D; Stapleton LM; Yu AC; Muir B; Howard S; Postma A; Appel EA
    Sci Transl Med; 2020 Jul; 12(550):. PubMed ID: 32611683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation Excipients and Their Role in Insulin Stability and Association State in Formulation.
    Maikawa CL; Nguyen LT; Mann JL; Appel EA
    Pharm Res; 2022 Nov; 39(11):2721-2728. PubMed ID: 35978148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site.
    Khadria A; Paavola CD; Maslov K; Valenzuela FA; Sperry AE; Cox AL; Cao R; Shi J; Brown-Augsburger PL; Lozano E; Blankenship RL; Majumdar R; Bradley SA; Beals JM; Oladipupo SS; Wang LV
    Mol Metab; 2022 Aug; 62():101522. PubMed ID: 35671972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats.
    Maikawa CL; Chen PC; Vuong ET; Nguyen LT; Mann JL; d'Aquino AI; Lal RA; Maahs DM; Buckingham BA; Appel EA
    Adv Sci (Weinh); 2021 Nov; 8(21):e2101575. PubMed ID: 34499434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues.
    Maikawa CL; Smith AAA; Zou L; Meis CM; Mann JL; Webber MJ; Appel EA
    Adv Ther (Weinh); 2020 Jan; 3(1):. PubMed ID: 32190729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
    Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
    Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ultrafast-acting insulin analogues in the management of diabetes.
    Kruger DF; Novak LM
    J Am Assoc Nurse Pract; 2019 Sep; 31(9):537-548. PubMed ID: 31385938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Humalog® 200 U/ml KwikPen™].
    Scheen AJ
    Rev Med Liege; 2015 Oct; 70(10):527-31. PubMed ID: 26727843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic Polyacrylamide Excipients Lead to a Record-Breaking Fast-Acting Insulin.
    Angsantikul P; Mitragotri S
    Trends Pharmacol Sci; 2020 Oct; 41(10):681-684. PubMed ID: 32891428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.
    Roach P; Yue L; Arora V
    Diabetes Care; 1999 Aug; 22(8):1258-61. PubMed ID: 10480767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and Glucodynamic Responses of Ultra Rapid Lispro vs Lispro Across a Clinically Relevant Range of Subcutaneous Doses in Healthy Subjects.
    Leohr J; Dellva MA; LaBell E; Coutant DE; Klein O; Plum-Moerschel L; Zijlstra E; Linnebjerg H
    Clin Ther; 2020 Sep; 42(9):1762-1777.e4. PubMed ID: 32900535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic fibrillation of fast-acting insulin analogs.
    Woods RJ; Alarcón J; McVey E; Pettis RJ
    J Diabetes Sci Technol; 2012 Mar; 6(2):265-76. PubMed ID: 22538135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes.
    Meiffren G; Herbrand T; Anastassiadis E; Klein O; DeVries JH; Heise T; Alluis B; Mégret C; Gaudier M; Soula O; Plum-Mörschel L
    Diabetes Obes Metab; 2019 Jul; 21(7):1570-1575. PubMed ID: 30828929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling Insulin Oligomeric States by
    Falk BT; Liang Y; McCoy MA
    J Pharm Sci; 2020 Jan; 109(1):922-926. PubMed ID: 31449814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.
    Teska BM; Alarcón J; Pettis RJ; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Aug; 103(8):2255-67. PubMed ID: 24909933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
    Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humalog (lispro) for type 2 diabetes.
    Esposito K; Capuano A; Giugliano D
    Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
    Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
    Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.